INC424
Showing 76 - 100 of 519
Non Muscular Invasive Bladder Cancer Trial in Worldwide (CG0070, n-dodecyl-B-D-maltoside)
Recruiting
- Non Muscular Invasive Bladder Cancer
- CG0070
- n-dodecyl-B-D-maltoside
-
Homewood, Alabama
- +58 more
Jun 16, 2022
Evaluation of the LVivo Image Quality Scoring (IQS)
Completed
- Heart Diseases
- +6 more
-
Beer-Sheva, IsraelSoroka university medical center
Sep 28, 2022
Breast Cancer Trial in United States (Breast Cancer Index (BCI) Risk of Recurrence & Extended Endocrine Benefit Test)
Recruiting
- Breast Cancer
- Breast Cancer Index (BCI) Risk of Recurrence & Extended Endocrine Benefit Test
-
Daphne, Alabama
- +104 more
Aug 17, 2022
Relapsing Multiple Sclerosis Trial in Worldwide (Evobrutinib, Placebo (match to Teriflunomide), Teriflunomide)
Active, not recruiting
- Relapsing Multiple Sclerosis
- Evobrutinib
- +3 more
-
Mobile, Alabama
- +278 more
Nov 7, 2022
Chronic Hepatitis C(CHC) Trial in Kawasaki City (MP-424, RBV(24 weeks), IFN beta(24 weeks))
Completed
- Chronic Hepatitis C(CHC)
- MP-424
- +4 more
-
Kawasaki City, Takatsu-ku, JapanToranomon Hospital
Jan 5, 2018
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)
Recruiting
- Leukemia
- +19 more
- CYNK-001
-
Denver, Colorado
- +9 more
Sep 9, 2022
HIV, HIV Trial in Worldwide (E/C/F/TAF, E/C/F/TDF, EFV/FTC/TDF)
OCD Trial in Worldwide (Troriluzole, Placebo)
Recruiting
- Obsessive-Compulsive Disorder
- Troriluzole
- Placebo
-
Phoenix, Arizona
- +108 more
Aug 18, 2022
Acute HIV Infection Trial in Brazil, Peru, United States (biological, other, drug)
Not yet recruiting
- Acute HIV Infection
- VRC07-523LS
- +3 more
-
Birmingham, Alabama
- +35 more
Jan 30, 2023
Psoriatic Arthritis Trial in Worldwide (Placebo, Risankizumab)
Active, not recruiting
- Psoriatic Arthritis
- Placebo
- Risankizumab
-
Anniston, Alabama
- +255 more
Feb 23, 2022
Heart Failure, Heart Failure With Preserved Ejection Fraction Trial in Worldwide (LY3540378, Placebo)
Not yet recruiting
- Heart Failure
- Heart Failure With Preserved Ejection Fraction
- LY3540378
- Placebo
-
Tucson, Arizona
- +89 more
Nov 14, 2022
Persona Revision Knee System Outcomes
Recruiting
- Arthroplasty Complications
- +3 more
- Persona Revision Knee System
-
Fayetteville, Arkansas
- +12 more
May 9, 2022
Acute Pancreatitis, Systemic Inflammatory Response Syndrome Trial in United States (CM-4620 Injectable Emulsion or CM-4620-IE,
Recruiting
- Acute Pancreatitis
- Systemic Inflammatory Response Syndrome
- CM-4620 Injectable Emulsion or CM-4620-IE
- Placebo
-
Long Beach, California
- +32 more
Jan 9, 2023
Prostate Cancer, Prostate Adenocarcinoma Trial in Canada, United States (Radical Prostatectomy, TULSA Procedure)
Recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- Radical Prostatectomy
- TULSA Procedure
-
Tarzana, California
- +7 more
Aug 10, 2022
Total Knee Arthroplasty Trial in Aurora (Standard Rehabilitation + Neuromuscular Electrical Stimulation and Blood Flow
Completed
- Total Knee Arthroplasty
- Standard Rehabilitation + Neuromuscular Electrical Stimulation and Blood Flow Restriction
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Feb 18, 2022